Evidence map›Paper›PMID 24404336›Full record

ArticleBiomolecules & therapeutics2013

Neuroprotective Effects of a Butanol Fraction of Rosa hybrida Petals in a Middle Cerebral Artery Occlusion Model.

Goeun Yang, Dongsun Park, Sun Hee Lee, Dae-Kwon Bae, Yun-Hui Yang, Jangbeen Kyung, Dajeong Kim, Ehn-Kyoung Choi, Jin Tae Hong, Heon-Sang Jeong and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Biomolecules & therapeutics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Integrative cancer therapies
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Goeun YangCollege of Veterinary Medicine, Chungbuk National University, Cheongju 361-763, Republic of Korea.
Dongsun ParkCollege of Veterinary Medicine, Chungbuk National University, Cheongju 361-763, Republic of Korea.
Sun Hee LeeCollege of Veterinary Medicine, Chungbuk National University, Cheongju 361-763, Republic of Korea.
Dae-Kwon BaeCollege of Veterinary Medicine, Chungbuk National University, Cheongju 361-763, Republic of Korea.
Yun-Hui YangCollege of Veterinary Medicine, Chungbuk National University, Cheongju 361-763, Republic of Korea.
Jangbeen KyungCollege of Veterinary Medicine, Chungbuk National University, Cheongju 361-763, Republic of Korea.
Dajeong KimCollege of Veterinary Medicine, Chungbuk National University, Cheongju 361-763, Republic of Korea.
Ehn-Kyoung ChoiCollege of Veterinary Medicine, Chungbuk National University, Cheongju 361-763, Republic of Korea.
Jin Tae HongCollege of Pharmacy, Chungbuk National University, Cheongju 361-763, Republic of Korea.
Heon-Sang JeongDepartment Food Science and Technology, Chungbuk National University, Cheongju 361-763, Republic of Korea.
Hee Jung KimDepartment of Marine Molecular Biotechnology, College of Life Science, Gangneung-Wonju National University, Gangneung 210- 702, Republic of Korea.
Su Kil JangDepartment of Marine Molecular Biotechnology, College of Life Science, Gangneung-Wonju National University, Gangneung 210- 702, Republic of Korea.
Seong Soo JooDepartment of Marine Molecular Biotechnology, College of Life Science, Gangneung-Wonju National University, Gangneung 210- 702, Republic of Korea.
Yun-Bae KimCollege of Veterinary Medicine, Chungbuk National University, Cheongju 361-763, Republic of Korea.
Chungbuk National University · KRGangneung–Wonju National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neuroprotective effects of a butanol fraction of white rose petal extract (WRPE-BF) were investigated in a middle cerebral artery occlusion (MCAO) model. Seven week-old male rats were orally administered WRPE-BF for 2 weeks and subjected to MCAO for 2 h, followed by reperfusion. Twenty-four h later, MCAO-induced behavioral dysfunctions were markedly improved in a dose-dependent manner by pretreatment with WRPE-BF. Moreover, higher dose of WRPE-BF not only decreased infarction area but also effectively reduced astrogliosis. The expression of inducible nitric oxide synthase, cyclooxygenase-2, and glial fibrillary acidic protein in MCAO model were markedly inhibited by WRPE-BF treatment. Notably, WRPE-BF decreased nitric oxide and malondialdehyde levels in the striatum and subventricular zone of stroke-challenged brains. These data suggested that WRPE-BF may exert its neuroprotective effects via anti-oxidative and anti-inflammatory activities against ischemia-reperfusion brain injury and could be a good candidate as a therapeutic target for ischemic stroke.

Indexed as

Anti-inflammationAntioxidationGlial fibrillary acidic proteinIschemic brain injuryMiddle cerebral artery occlusionRosa hybrida

Identifiers

PMID24404336
PMCPMC3879917
OpenAlexW2017329329

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.